DEUTSCHE BANK AG\ - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 69 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q4 2020$6,0001,371
+68450.0%
0.00%
Q3 2020$020.0%0.00%
Q2 2020$0
-100.0%
2
-99.8%
0.00%
Q4 2019$15,000
+200.0%
1,155
+188.8%
0.00%
Q2 2019$5,0004000.00%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q2 2019
NameSharesValueWeighting ↓
CHI Advisors LLC 7,987,396$2,963,3230.79%
TANG CAPITAL MANAGEMENT LLC 2,000,000$742,0000.11%
Artal Group S.A. 1,803,858$6690.04%
Forefront Analytics, LLC 164,894$61,1750.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,161,707$1,172,9930.02%
Temasek Holdings (Private) Ltd 4,319,049$1,602,3670.01%
FEDERATED HERMES, INC. 8,401,687$3,117,0260.01%
Cormorant Asset Management, LP 256,649$950.01%
Lane Generational LLC 10,828$4,0170.01%
Allegheny Financial Group LTD 28,750$10,6660.00%
View complete list of ORCHARD THERAPEUTICS PLC shareholders